ZIM Laboratories to Invest in European, GCC Subsidiaries

MT Newswires Live
03/31

ZIM Laboratories (NSE:ZIMLAB, BOM:541400) board approved an investment of up to 400,000 euros in its wholly owned subsidiary, SIA ZIM Laboratories, to support business expansion in Europe, according to an Indian bourse filing on Friday.

The company's shareholding in the subsidiary remains unchanged at 100%, the filing said.

Additionally, ZIM Laboratories FZE, a wholly owned subsidiary of ZIM Laboratories, will invest up to 466,000 Emirati Dirham in its step-down subsidiary, ZIM Scientific Office, to support growth in the GCC region, the filing added.

The investment does not alter ZIM Laboratories FZE's full ownership of the entity.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10